gabexate has been researched along with Pulmonary Embolism in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Pulmonary Embolism: Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maeta, H | 1 |
Imawaki, S | 1 |
Shiraishi, Y | 1 |
Tanaka, S | 1 |
Shirakawa, Y | 1 |
Komatsu, H | 1 |
Miyazawa, T | 1 |
Tanemori, N | 1 |
Utsumi, T | 1 |
Katayama, S | 1 |
Furukawa, N | 1 |
2 other studies available for gabexate and Pulmonary Embolism
Article | Year |
---|---|
[Clinical profile and treatment of acute pulmonary embolism].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Blood Gas Analysis; | 1992 |
[Balloon occlusion pulmonary angiography and anticoagulant-antithrombotic therapy in ARDS-associated pulmonary vascular thrombosis].
Topics: Adult; Aged; Gabexate; Guanidines; Heparin; Humans; Male; Middle Aged; Pulmonary Artery; Pulmonary E | 1991 |